Download
s00392-021-01939-3.pdf 872,33KB
WeightNameValue
1000 Titel
  • Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities
1000 Autor/in
  1. Rieder, Marina |
  2. Gauchel, Nadine |
  3. Kaier, Klaus |
  4. Jakob, Carolin |
  5. Borgmann, Stefan |
  6. Classen, Annika Y. |
  7. Schneider, Jochen |
  8. Eberwein, Lukas |
  9. Lablans, Martin |
  10. Rüthrich, Maria |
  11. Dolff, Sebastian |
  12. Wille, Kai |
  13. Haselberger, Martina |
  14. Heuzeroth, Hanno |
  15. Bode, Christoph |
  16. von zur Mühlen, Constantin |
  17. Rieg, Siegbert |
  18. Duerschmied, Daniel |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-21
1000 Erschienen in
1000 Quellenangabe
  • 111(3):322-332
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00392-021-01939-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453472/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Aims!#!Coagulopathy and venous thromboembolism are common findings in coronavirus disease 2019 (COVID-19) and are associated with poor outcome. Timely initiation of anticoagulation after hospital admission was shown to be beneficial. In this study we aim to examine the association of pre-existing oral anticoagulation (OAC) with outcome among a cohort of SARS-CoV-2 infected patients.!##!Methods and results!#!We analysed the data from the large multi-national Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) from March to August 2020. Patients with SARS-CoV-2 infection were eligible for inclusion. We retrospectively analysed the association of pre-existing OAC with all-cause mortality. Secondary outcome measures included COVID-19-related mortality, recovery and composite endpoints combining death and/or thrombotic event and death and/or bleeding event. We restricted bleeding events to intracerebral bleeding in this analysis to ensure clinical relevance and to limit reporting errors. A total of 1 433 SARS-CoV-2 infected patients were analysed, while 334 patients (23.3%) had an existing premedication with OAC and 1 099 patients (79.7%) had no OAC. After risk adjustment for comorbidities, pre-existing OAC showed a protective influence on the endpoint death (OR 0.62, P = 0.013) as well as the secondary endpoints COVID-19-related death (OR 0.64, P = 0.023) and non-recovery (OR 0.66, P = 0.014). The combined endpoint death or thrombotic event tended to be less frequent in patients on OAC (OR 0.71, P = 0.056).!##!Conclusions!#!Pre-existing OAC is protective in COVID-19, irrespective of anticoagulation regime during hospital stay and independent of the stage and course of disease.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Europe [MeSH]
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal SARS-CoV-2/drug effects [MeSH]
lokal Thrombosis
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Thromboembolism/virology [MeSH]
lokal COVID-19
lokal Blood Coagulation Disorders/drug therapy [MeSH]
lokal COVID-19/mortality [MeSH]
lokal Male [MeSH]
lokal Blood Coagulation Disorders/virology [MeSH]
lokal Original Paper
lokal Comorbidity [MeSH]
lokal Oral anticoagulation
lokal Thromboembolism/drug therapy [MeSH]
lokal Anticoagulants/therapeutic use [MeSH]
lokal SARS-CoV-2
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UmllZGVyLCBNYXJpbmE=|https://orcid.org/0000-0002-1276-9920|https://frl.publisso.de/adhoc/uri/S2FpZXIsIEtsYXVz|https://frl.publisso.de/adhoc/uri/SmFrb2IsIENhcm9saW4=|https://frl.publisso.de/adhoc/uri/Qm9yZ21hbm4sIFN0ZWZhbg==|https://frl.publisso.de/adhoc/uri/Q2xhc3NlbiwgQW5uaWthIFku|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLCBKb2NoZW4=|https://frl.publisso.de/adhoc/uri/RWJlcndlaW4sIEx1a2Fz|https://frl.publisso.de/adhoc/uri/TGFibGFucywgTWFydGlu|https://frl.publisso.de/adhoc/uri/UsO8dGhyaWNoLCBNYXJpYQ==|https://frl.publisso.de/adhoc/uri/RG9sZmYsIFNlYmFzdGlhbg==|https://frl.publisso.de/adhoc/uri/V2lsbGUsIEthaQ==|https://frl.publisso.de/adhoc/uri/SGFzZWxiZXJnZXIsIE1hcnRpbmE=|https://frl.publisso.de/adhoc/uri/SGV1emVyb3RoLCBIYW5ubw==|https://frl.publisso.de/adhoc/uri/Qm9kZSwgQ2hyaXN0b3Bo|https://frl.publisso.de/adhoc/uri/dm9uIHp1ciBNw7xobGVuLCBDb25zdGFudGlu|https://frl.publisso.de/adhoc/uri/UmllZywgU2llZ2JlcnQ=|https://frl.publisso.de/adhoc/uri/RHVlcnNjaG1pZWQsIERhbmllbA==
1000 Hinweis
  • DeepGreen-ID: 11619ebc0e8c48d8994282d52a2cab8c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450866.rdf
1000 Erstellt am 2023-05-11T11:19:06.130+0200
1000 Erstellt von 322
1000 beschreibt frl:6450866
1000 Zuletzt bearbeitet 2023-10-20T10:26:34.639+0200
1000 Objekt bearb. Fri Oct 20 10:26:34 CEST 2023
1000 Vgl. frl:6450866
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450866 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source